Hisakazu Yamagishi - Concepedia

Author

Hisakazu Yamagishi

Kyoto Prefectural University of Medicine

Also Known As

H Yamagishi, HISAKAZU YAMAGISHI, Hisakazu YAMAGISHI, Hisakazu Yamagishi

320

Publications

7.3K

Citations

H-Index

149

Concepts

All Affiliations

Kyoto Prefectural University of Medicine Kyoto University Kyoto first Red Cross hospital

About

Hisakazu Yamagishi is an author at Kyoto Prefectural University of Medicine specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	61	4.3K
2	Engineering	12	14	476
3	Biomedical Engineering	8	8	301
4	Health Sciences	7	7	525
5	Biochemistry	1	1	308

Hisakazu Yamagishi

126

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer Qing-Lin Li, Kosei Ito, Chohei Sakakura, Cell Tumor BiologyOncologyCausal RelationshipGastrointestinal OncologyOncogenic Agent	2002	1K
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Nature Medicine VaccinationCancer ImmunosurveillanceMultipeptide Immune ResponseMedicineCancer Vaccine Ima901	2012	777
Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell Line Katsunori Nakano, Takakazu Mizuno, Yoshihiro Sowa, Journal of Biological Chemistry	1997	395
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes Shojiro Kikuchi, Masaki Hata, Kanehisa Fukumoto, Nature Genetics BiochemistryRadixin Deficiency CausesBiliary TractLiver PhysiologyPhysiology	2002	308
Amplification and over-expression of theAIB1 nuclear receptor co-activator gene in primary gastric cancers Chouhei Sakakura, Akeo Hagiwara, Rie Yasuoka, International Journal of Cancer Gene AmplificationEngineeringPathologyCancer BiologyTumor Biology	2000	160
A Role for p27/Kip1 in the Control of Cerebellar Granule Cell Precursor Proliferation Kazuhiro Miyazawa, Toshiyuki Himi, Veronica Garcia, Journal of Neuroscience Signal TransductionDevelopmental BiologyCell DivisionCell RegulationCell Signaling	2000	152
Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy Takeshi Shimizu, Tsunao Kishida, Urara Hasegawa, Biochemical and Biophysical Research Communications NanomedicineTumor ImmunologyNanogel DdsImmunologyImmunoediting	2008	143
Intrathoracic esophageal replacement by in situ tissue-engineered esophagus Yuen Nakase, Tatsuo Nakamura, Shuichi Kin, Journal of Thoracic and Cardiovascular Surgery Regenerative MedicineEsophagusSitu Tissue-engineered EsophagusEsophageal CancerGastroenterology	2008	125
Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine‐18‐labeled fluoro‐deoxyglucose (FDG‐PET) Toshimori Koh, Hiroki Taniguchi, Akihiro Yamaguchi, Journal of Surgical Oncology	2003	116
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma Tsunao Kishida, Hidetsugu Asada, Yoshiki Itokawa, Molecular Therapy	2003	109

Page 1